Business Wire

NBT and CET Sign EPC Contracts to Build the 750MW Zophia II and Zophia III Wind Farms in Ukraine

Share

NBT AS (“NBT”), a utility-scale wind power developer based in Oslo and China Electric Power Equipment and Technology Co., Ltd. (“CET”), the EPC subsidiary of State Grid Corporation of China, have signed two EPC contracts for building the 300MW Zophia II wind farm and the 450MW Zophia III wind farm located in the Zaporizhia region of Ukraine. In addition, NBT, CET, Industrial Commercial Bank of China (“ICBC”), the Export-Import Bank of China (“Exim Bank of China”) and China Construction Bank (“CCB”) also signed the Preliminary Financing Arrangement Agreement to finance Zophia II and Zophia III wind farms which together will be the largest onshore wind farm in Europe. NBT and CET also signed a Strategic Cooperation Agreement to cooperate on a global basis on future renewable energy projects.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191023005388/en/

NBT and CET Sign EPC Contracts to Build the 750MW Zophia II and Zophia III Wind Farms in Ukraine (Photo: Business Wire)

NBT and CET Sign EPC Contracts to Build the 750MW Zophia II and Zophia III Wind Farms in Ukraine (Photo: Business Wire)

The 300MW Zophia II and 450MW Zophia III wind farms (“Zophia wind farms”) will become the largest onshore wind farm in Europe once completed with total capacity of 750MW. The total investment for the Zophia wind farms will exceed €1 billion which is equal to approximately 1% of the gross domestic product of Ukraine.

The signing ceremony held in Beijing at State Grid Corporation of China’s corporate headquarters was witnessed by the Ambassador of the Royal Norwegian Embassy in China, Ms. Signe Brudeset, First Secretary of the Embassy of Ukraine to the People's Republic of China, Mr. Oleh Malyi, Mr. Liu Jianchang from ICBC, Mr. Bai Huafeng from Exim Bank of China, Mr. Wu Powei from CCB and the senior leadership of State Grid Corporation of China.

NBT is building on the success of its 250MW Syvash wind farm which achieved the first international financial close for €262 million of project financing for a wind farm of that scale in Ukraine in early 2019. With the support of ICBC, Exim Bank of China and CCB for €500 million of senior debt, NBT has a plan to engage additional international banks into the bank syndicate for another €250 million of project financing and aims for an even larger financial close for Zophia.

The Zophia wind farms are being built to very high international standards, conforming to EBRD Performance Standards and Equator Principles. The electricity generated from Zophia will be sold to state-owned company “Guaranteed Buyer State Enterprise” - Ukraine’s wholesale electricity market operator. Once the two wind farms are completed, it will have a planned production of 2,900 GWh per year and generate enough electricity to power the needs of approximately 340,000 households. The Zophia wind farms are expected to reduce CO2 emissions by 1,600,000 tons per year and make a substantial positive impact on the environment.

The Zophia wind farm will bring significant economic development and tax revenues to the Zaporizhia region, provide up to two thousand jobs during construction and have a lasting economic impact even after its construction is completed.

Joar Viken, CEO of NBT, said: “We are excited to sign the EPC contracts with CET for the largest onshore wind project in Europe. We are very happy to work with CET and State Grid Corporation of China to build a huge wind farm in Ukraine that will benefit the people of Ukraine and the environment. We also would like to thank ICBC, Exim Bank of China and China Construction Bank for their support and look forward to working closely with them to finance our Zophia wind farms.”

Jia Zhichiang, Chairman of CET, stated: “We are very eager to work with NBT to build the 750MW Zophia wind farms. Since Ukraine is in the Belt and Road Initiative, we are delighted that we can enter Ukraine with this large construction project. With our strengths in international EPC projects, project management, technology, building world class transmission lines including ultra-high voltage transmission lines, we will bring unparalleled excellence to successfully complete the Zophia wind farms. We are thrilled to enter the Ukrainian market and hope to conduct more business such as helping the Government of Ukraine upgrade its grid infrastructure and building more top-notch power projects.”

About China Electric Power and Technology Co. Ltd.

CET, as a wholly-owned subsidiary of State Grid Corporation of China and the platform of its overseas business, is a professional world-leading enterprise in undertaking international power projects in “investment-construction-operation” mode and has over 20 permanent establishments around the world.

About NBT

NBT AS is a developer and operator of utility-scale wind farms in emerging markets. The company was founded in 2004 and is based in Oslo, Norway. NBT has operations in Norway, China, Cyprus, Sweden, Singapore and Ukraine. For more information, go to www.nbtas.no.

Contact information

Media relations:
Anniken Jensen (NBT)
+47 452 69 023
Anniken.Jensen@nbtas.no

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex and Republic of Ireland Expand Long-Term Cystic Fibrosis Medicines Reimbursement Agreement to Include Triple Combination Therapy for All Eligible Patients Ages 12 and Over Once Licensed13.12.2019 21:55:00 EETPress release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today confirmed that, following recent collaborative discussions, it has negotiated an agreement with the Health Service Executive (HSE) in the Republic of Ireland to expand the existing long-term cystic fibrosis (CF) reimbursement agreement to include the triple combination regimen (elexacaftor, tezacaftor and ivacaftor), which is under review and pending approval by the European Medicines Agency, for all eligible patients ages 12 and older in line with the potential future licensed indication. This expands the existing agreement which had already included access to current and future Vertex medicines for people in Ireland with CF of any age who: Have one of the specified mutations as included in the KALYDECO® marketing authorization (G551D, G551S, S549R, G1244E, S1251N, G1349D, S1255P, G178R or S549N) or Are homozygous for the F508del mutation or Are heterozygous for the F508del mutation and have a specified mutation (P67L, D579G, D1

CreditLens™ Solution Receives SOC 2 Attestation Report13.12.2019 18:17:00 EETPress release

Moody’s Analytics announced today that the CreditLens software-as-a-service (SaaS) solution has received an attestation report from the American Institute of Certified Public Accountants (AICPA) System and Organization Controls (SOC 2). The SOC 2 report details the security and availability of customer data in the CreditLens SaaS solution, and denotes its adherence to the AICPA’s security and availability controls standards. Built on the latest cloud-based technology, the CreditLens platform helps businesses digitally transform their commercial credit processes to make faster and better-informed decisions. It facilitates process automation and helps clients improve their efficiency, reduce errors, and streamline workflows. A SOC 2 report ensures that a company’s information security measures are in line with the unique parameters of today’s cloud requirements. The report addresses a service organization's controls that relate to operations and compliance, as outlined by the AICPA's Tru

CHMP Grants Positive Opinion for Expanded Use of Darzalex®▼ (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone (VTd) for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible13.12.2019 14:47:00 EETPress release

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended broadening the existing marketing authorisation for Darzalex®▼ (daratumumab) to include the use of daratumumab in combination with bortezomib, thalidomide and dexamethasone (VTd) for the treatment of adult patients with newly diagnosed patients with multiple myeloma who are eligible for autologous stem cell transplant (ASCT). The Positive Opinion is supported by data from Part 1 of the Phase 3 CASSIOPEIA (MMY3006) study, published in The Lancet 3 in June 2019, and presented at the 2019 American Society of Clinical Oncology (ASCO) Meeting. Additional information about this study can be found at www.ClinicalTrials.gov (NCT02541383). “Today’s Opinion takes us a step closer to offering the first daratumumab combination regimen to transplant eligible patients, redefining treatment for those people newl

Janssen Receives Positive CHMP Opinion for Expanded Use of Erleada® (apalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer13.12.2019 14:40:00 EETPress release

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending approval for expanding the use of Erleada® (apalutamide) to include the treatment of adult men with metastatic hormone-sensitive prostate cancer (mHSPC) in combination with androgen deprivation therapy (ADT).2 The CHMP’s Positive Opinion will now be reviewed by the European Commission (EC), which has the authority to grant approval for the new use of apalutamide. The Positive Opinion is based on data from the Phase 3 TITAN study, which assessed the addition of apalutamide to ADT – the current standard of care in mHSPC – in a broad range of patients with mHSPC, regardless of disease volume, prior treatment with docetaxel or staging at initial diagnosis. The dual primary endpoints of the study were overall survival (OS) and radiographic progression-free survival (rPFS). Ap

German Player Karl Rupprec Wins 2019 Boyaa Poker Tournament Europe13.12.2019 12:24:00 EETPress release

On December 8, the sixth edition of the BPT (Boyaa Poker Tournament) came to an end. King's Resort in the Czech Republic celebrated this BPT Europe that enjoyed 600 cumulative participants from 20 countries. In the end, Karl Rupprec, from Germany, won the Main Event Championship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191213005109/en/ (Photo: Business Wire) Highlights of the BPT Europe 2019 final The BPT Europe 2019 Main Event began on December 8 at 2:00 p.m., Czech Republic time. After 9 hours of Texas Poker, players Ondrej Drozd from the Czech Republic and Karl Rupprec from Germany reached the last heads-up. In the end, Karl Rupprec, who started with half of his opponent's chips, reversed the situation with his two nines, winning the championship. Heads-up Highlights: Karl Rupprec pair 9 and Ondrej Drozd 2, 5. The flop was 2, Q, 9, so Karl Rupprec got three of a kind, and Ondrej Drozd got pair 2. Rupprec pretended

Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Adopted by Italian Designed Architectural Lighting Brand for Motorized Luminaire with Smart Wireless Controls13.12.2019 12:00:00 EETPress release

Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global innovator of LED technology, announced that it has achieved smart lighting design with SunLike Series natural spectrum LEDs in cooperation with Casambi Technologies Oy (“Casambi”), a leading developer of wireless lighting control systems based on Bluetooth Low Energy (BLE), and it has been adopted for the Italian designed architectural lighting brand formalighting Ltd. (“formalighting”), a global manufacturer of Italian designed architectural lighting systems and solutions for a new product line which offers motorized luminaire with smart wireless controls. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191213005009/en/ SunLike implemented in motion lamps (Photo: Business Wire) The SunLike COB LED packages have been adopted by formalighting for the new fixtures, Moto-Zero 40 Compasso and Moto-Zero 66 Zoom, in track mounted motorized spotlight range. In this sect

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom